Literature DB >> 17485361

Genetic etiology of hereditary prostate cancer.

Wendy J Langeberg1, William B Isaacs, Janet L Stanford.   

Abstract

Prostate cancer (PC) is a pervasive disease both in terms of incidence and mortality, yet little is known about its etiologic factors. Twin and segregation studies provide evidence for an inherited genetic component to the etiology of PC, yet over a dozen family-based genetic linkage analyses have not been able to consistently identify susceptibility loci. This chapter will review these studies, describe the challenges of this endeavor, and describe efforts to confront these challenges, such as using larger sets of families and more homogeneous subgroups.

Entities:  

Mesh:

Year:  2007        PMID: 17485361     DOI: 10.2741/2374

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  27 in total

Review 1.  A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.

Authors:  Brian T Helfand; Carly A Conran; Jianfeng Xu; William J Catalona
Journal:  Curr Opin Urol       Date:  2017-09       Impact factor: 2.309

2.  Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

Authors:  Joan P Breyer; Kate M McReynolds; Brian L Yaspan; Kevin M Bradley; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

3.  Mutational landscape of candidate genes in familial prostate cancer.

Authors:  Anna M Johnson; Kimberly A Zuhlke; Chris Plotts; Shannon K McDonnell; Sumit Middha; Shaun M Riska; Daniel J Schaid; Stephen N Thibodeau; Julie A Douglas; Kathleen A Cooney
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

4.  Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.

Authors:  Mezbah U Faruque; Rabindra Paul; Luisel Ricks-Santi; Emmanuel Y Jingwi; Chiledum A Ahaghotu; Georgia M Dunston
Journal:  Anticancer Res       Date:  2015-05       Impact factor: 2.480

5.  Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.

Authors:  Kristin Gunderson; Christopher Y Wang; Ruoxiang Wang
Journal:  Cancer Epidemiol       Date:  2010-12-16       Impact factor: 2.984

6.  Germline mutations in HOXB13 and prostate-cancer risk.

Authors:  Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

7.  Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.

Authors:  Florian R Schroeck; Kimberly A Zuhlke; Javed Siddiqui; Rabia Siddiqui; Kathleen A Cooney; John T Wei
Journal:  J Urol       Date:  2012-10-02       Impact factor: 7.450

Review 8.  Recurrent gene fusions in prostate cancer.

Authors:  Chandan Kumar-Sinha; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Nat Rev Cancer       Date:  2008-06-19       Impact factor: 60.716

9.  Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.

Authors:  Albert M Levin; Mitchell J Machiela; Kimberly A Zuhlke; Anna M Ray; Kathleen A Cooney; Julie A Douglas
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 10.  The role of the BRCA2 gene in susceptibility to prostate cancer revisited.

Authors:  Elaine A Ostrander; Miriam S Udler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.